Ending Parkinson’s: Could a ‘Growth Factor’ Hold the Key?

(DGIwire) — A recent human trial testing the clinical effectiveness of a growth-factor compound in those with Parkinson’s disease showed promising results. The study, published in the Journal of Clinical Investigation, raised the possibility that there could, in the future, be regenerative treatments for those suffering from Parkinson’s. Better still, the treatments would use the […]

close